azobenzene

photosensor molecule known to undergo reversible isomerization from trans to cis on illumination with photons of appropriate wavelength; RN given refers to cpd without isomeric designation; structure

Also Known As:

Networked: 26 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Flannery, John G: 2 articles (10/2015 - 12/2014)
2.	Holt, Amy E: 2 articles (10/2015 - 12/2014)
3.	Gaub, Benjamin M: 2 articles (10/2015 - 12/2014)
4.	Isacoff, Ehud Y: 2 articles (10/2015 - 12/2014)
5.	Berry, Michael H: 2 articles (10/2015 - 12/2014)
6.	Perche, Federico: 1 article (01/2016)
7.	Biswas, Swati: 1 article (01/2016)
8.	Torchilin, Vladimir P: 1 article (01/2016)
9.	Patel, Niravkumar R: 1 article (01/2016)
10.	Ginovska, Bojana: 1 article (09/2015)

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 02/01/1972 - "Influence of blood transfusion on induction of hepatoma inrats fed 4-(dimethylamino) azobenzene." 06/01/1973 - "Heterogeneity of ferritin from 3'-methyl-4-(dimethylamino) azobenzene-induced hepatomas." 04/01/1968 - "Inhibitory effect of dehydroacetic acid on induction of hepatoma in rats fed 4-(dimethylamino) azobenzene." 10/01/1946 - "Effect of cystine per se on the formation of hepatomas in rats following the ingestion of p-dimethylamino-azobenzene." 10/01/1978 - "Enhancing effect of phenobarbital on the development of enzyme-altered islands and hepatocellular carcinomas initiated by 3'-methyl-4-(dimethylamino) azobenzene or diethylnitrosamine."
2.	Neoplasms (Cancer) 03/27/2015 - "The azobenzene unit used as a photochemically and thermally switchable linker in the assembly of a bis-calix[4]pyrrole receptor provides a means to modulate the binding of bis-carboxylates of significant biological importance in cancer research. " 01/25/2010 - "It has also been claimed to have potential anti-cancer properties in vivo in mice chronically fed liver carcinogens, p-dimethylamino azobenzene (initiator) and phenobarbital (promoter). " 08/01/1985 - "Ten of the 17 carcinogens negative in the rat liver foci assay are believed to exhibit tumor-promoting activity; 3 are direct-acting alkylating agents (dimethylsulfate, epichlorohydrin, and beta-propiolactone); and the remaining 3 are azobenzene, 1,2-dibromoethane, and thioacetamide. "
3.	Inflammation 01/01/1990 - "Allergic inflammation was induced by injecting an antigen solution into an air pouch made on the dorsum of immunized rats with the antigen azobenzene-arsonate-conjugated acetyl bovine serum albumin. " 01/01/1983 - "Chemotactic activity at the site of an allergic air-pouch inflammation induced with azobenzene-arsonate-conjugated acetyl bovine serum albumin as an antigen was studied and a close correlation of the chemotactic activity with the intensity of leukocyte migration was demonstrated. " 01/01/1987 - "The recurrence of allergic inflammation, as examined by exudate accumulation, infiltration of polymorphonuclear leukocytes into the exudate, edema formation, vascular permeability and prostaglandin E2 levels in the exudate, was induced by injecting the antigen, azobenzene arsonate-conjugated acetyl bovine serum albumin, into the capsule of the proliferative granulation tissue which had been formed by the first-time antigenic challenge injection into an air pouch in the dorsum of the sensitized rat. "
4.	Photophobia (Light Sensitivity) 03/17/2014 - "We now show how an OR can be combined with a synthetic azobenzene photoswitch to gain light sensitivity. " 10/01/2015 - "Optogenetic gene therapies are in development, but, to date, have suffered from the low light sensitivity of microbial opsins, such as channelrhodopsin and halorhodopsin, and azobenzene-based photoswitches. "
5.	Delayed Hypersensitivity (Hypersensitivity, Type IV) 11/10/1975 - "Delayed hypersensitivity to mono-azobenzene arsonate-N-acetyl-L-tyrosine. " 10/20/1975 - "Delayed hypersensitivity to mono-azobenzene-arsonate-N-acetyl-L-tyrosine. "

Related Drugs and Biologics

1.	arsonic acid
2.	Antigens
3.	Bovine Serum Albumin
4.	Phenobarbital (Luminal)
5.	Carcinogens
6.	N-acetyltyrosine
7.	Opsins
8.	Small Interfering RNA (siRNA)
9.	Halorhodopsins (Halorhodopsin)
10.	Glutamic Acid (Glutamate)

Related Therapies and Procedures

1.	Blood Transfusion (Blood Transfusions)